FDA Inspection
Hahnemann Laboratories, Inc., dba Alpine PharmaceuticalsHahnemann Laboratories, Inc., dba Alpine Pharmaceuticals – FDA Inspection, Apr 27, 2017
Record Details
This FDA Inspection record concerns Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals, with an inspection on April 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 27, 2017
- Product Type
- Drugs
View Company Profile
ID · 175df120-8275-4703-9b9b-eaf190ed40df
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1013205
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | Not classified | San Francisco District Office | |
| January 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals
- FDA Inspection 1261710 - 2025-01-31
- FDA Inspection 1116226 - 2020-01-28
- FDA Inspection 716637 - 2011-03-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.